Clinical trial
Effectiveness of Pulmozyme in Infants With Cystic Fibrosis
NCT00179998 · Nationwide Children's Hospital, Other · Completed
Key facts
| NCT number | NCT00179998 |
|---|---|
| Title | Effectiveness of Pulmozyme in Infants With Cystic Fibrosis |
| Official title | Efficacy of Pulmozyme in Infants and Young Children With Cystic Fibrosis |
| Lead sponsor | Nationwide Children's Hospital, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | Recombinant Human DNase (Pulmozyme), Placebos |
| Enrollment | 24 |
| Start date | Jan 1, 2005 |
| Primary completion | Oct 1, 2008 |
| Completion | Jul 1, 2016 |
| First posted | Sep 16, 2005 |
| Last update posted | May 9, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: